Bioxytran Market Cap

Bioxytran has a market cap or net worth of $13.22 million as of April 3, 2025. Its market cap has decreased by -32.34% in one year.

Market Cap

13.22M

Enterprise Value

14.15M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.14

Market Cap Chart

Since September 24, 2018, Bioxytran's market cap has decreased from 25.52M to 13.22M, a decrease of -48.20%. That is a compound annual growth rate of -9.59%.

Market Cap History

Date	Market Cap	% Change
Apr 1, 2025	13.22M	69.45%
Dec 31, 2024	7.80M	-64.29%
Dec 29, 2023	21.85M	-63.00%
Dec 30, 2022	59.05M	33.18%
Dec 31, 2021	44.34M	89.57%
Dec 30, 2020	23.39M	-4.77%
Dec 30, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	1.82B
SS Innovations International	1.76B
Nika Pharmaceuticals	1.02B
Veradigm	720.71M
Elite Pharmaceuticals	470.04M
Glass House Brands	383.49M
Northwest Biotherapeutics	309.83M
CytoDyn	288.56M

Market Cap Rankings